Search
Gain Therapeutics Inc
GANXAdd to Watchlist
1.800USD
-0.040-2.17%
Market hours 09/24, 13:33（ET）
76.77MMarket Cap
LossP/E TTM
GANX Financials
See Gain Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
76.77M
Dividend TTM
0.00
P/E TTM
-3.07
EPS TTM
-0.59
Revenue
--
Net Profit
-20.41M
ROE
-214.69%
ROA
-139.91%
Gain Therapeutics Inc Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
-0.11/-0.14
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its current assets were 22.24M, with a year-on-year change of 91.66.
What are the total assets of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its total assets of Gain Therapeutics Inc were 22.82M, with a year-on-year change of 88.22.
What are the total liabilities of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its total liabilities of Gain Therapeutics Inc were 4.25M, with a year-on-year change of -11.08.
What is the total equity of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its total equity of Gain Therapeutics Inc was 18.56M, with a year-on-year change of 152.94.
What is the net operating income of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its net operating income of Gain Therapeutics Inc was -18.71M, with a year-on-year change of 8.06.
What is the net financing of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its net financing of Gain Therapeutics Inc was 28.45M, with a year-on-year change of 118.63.
What is the Earnings Per Share (EPS) of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.61, with a year-on-year change of 31.45.
What is the net income of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its net income was -20.16M, with a year-on-year change of 1.23.
What is the debt-to-asset ratio of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 1.76, with a year-on-year change of -51.42.
What is the Return on Equity (ROE) of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -155.66, with a year-on-year change of 24.05.
What is the Return on Assets (ROA) of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -115.39, with a year-on-year change of 13.12.
What is the operating profit of Gain Therapeutics Inc?
According to Gain Therapeutics Inc's FY2025 earnings report, its operating profit was -18.71M, with a year-on-year change of 8.06.